Medtronic announced it has launched a clinical trial of an implantable cardioverter defibrillator with real-time tracking that would allow patients to send data on heart pressure and rate, body temperature and patient activity to their physicians. Doctors would be able to monitor a patient's condition and adjust medications or diet based on the data.

Related Summaries